Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Sarcoma 23Lymphoma 16Osteosarcoma 11Lymphoma, Large B-Cell, Diffuse 11Hodgkin Disease 11Testicular Neoplasms 10Lymphoma, Non-Hodgkin 10Teratoma 8Ovarian Neoplasms 7Testicular Germ Cell Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms 6Burkitt Lymphoma 6Recurrence 5Endodermal Sinus Tumor 5Central Nervous System Neoplasms 5Carcinoma, Embryonal 5Lymphoma, Large-Cell, Anaplastic 4Seminoma 3Rhabdomyosarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Germ Cell Cancer 3Neurofibrosarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Histiocytoma, Malignant Fibrous 3Fibrosarcoma 3Vomiting 2Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2

Interventions

Radiotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1Ifosfamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mixed Tumor, Mesodermal × Ifosfamide × Clear all
NCT00231842 2019-01-23

Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

Montefiore Medical Center

Phase 2 Completed
30 enrolled 9 charts
Gynecologic

Uterine Neoplasms, Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡